Covalent attachment of the SUMO-1 protein to the negative regulatory domain of the c-Myb transcription factor modifies its stability and transactivation capacity

被引:150
作者
Bies, J
Markus, J
Wolff, L
机构
[1] NCI, Cellular Oncol Lab, NIH, Bethesda, MD 20892 USA
[2] Slovak Acad Sci, Canc Res Inst, Dept Mol Virol, Bratislava 83391, Slovakia
关键词
D O I
10.1074/jbc.M110453200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transcription factor c-Myb is subject to several types of post-translational modifications, including phosphorylation, acetylation, and ubiquitination. These modifications regulate the transcription and transforming activity as well as the proteolytic stability of c-Myb. Here we report the covalent modification of c-Myb with the small ubiquitin-related protein SUMO-1. Mutational analysis identified two major sumolation sites (Lys(499) and Lys(523)) in the negative regulatory domain. Interestingly, the single mutation K523R completely abolished modification of c-Myb with SUMO-1, suggesting that sumolation of Lys(523) is required for modification of other lysines in c-Myb. In accordance with this observation, we found that the SUMO-1-conjugating enzyme Ubc9 interacted only with a region surrounding Lys(523) (also called the PEST/EVES motif). Experiments aimed at determining the proteolytic stability of sumolated and unmodified forms of c-Myb, revealed that at least two covalently attached SUMO-1 molecules dramatically increased the stability of c-Myb. However, mutations of the SUMO-1 modification sites did not alter its stability, suggesting that a mechanism(s) other than competition of ubiquitin and SUMO-1 for the same lysine is involved in the stabilization of sumolated c-Myb protein. Finally, the K523R mutant of c-Myb, entirely deficient in sumolation, was shown to have an increased transactivation capacity on a Myb-responsive promoter, suggesting that SUMO-1 negatively regulates the transactivation function of c-Myb. Thus, modification of c-Myb with SUMO-1 represents a novel mechanism through which the negative regulatory domain can exert its suppressing activity on c-Myb transactivation capacity.
引用
收藏
页码:8999 / 9009
页数:11
相关论文
共 59 条
  • [51] The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SURIO-1 modification
    Sampson, DA
    Wang, M
    Matunis, MJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (24) : 21664 - 21669
  • [52] Increased affinity of c-Myb for CREB-binding protein (CBP) after CBP-induced acetylation
    Sano, Y
    Ishii, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (05) : 3674 - 3682
  • [53] UBL1, a human ubiquitin-like protein associating with human RAD51/RAD52 proteins
    Shen, ZY
    PardingtonPurtymun, PE
    Comeaux, JC
    Moyzis, RK
    Chen, DJ
    [J]. GENOMICS, 1996, 36 (02) : 271 - 279
  • [54] Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1
    Sternsdorf, T
    Jensen, K
    Will, H
    [J]. JOURNAL OF CELL BIOLOGY, 1997, 139 (07) : 1621 - 1634
  • [55] Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9
    Tatham, MH
    Jaffray, E
    Vaughan, OA
    Desterro, JMP
    Botting, CH
    Naismith, JH
    Hay, RT
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (38) : 35368 - 35374
  • [56] Molecular cloning reveals that the p160 myb-binding protein is a novel, predominantly nucleolar protein which may play a role in transactivation by Myb
    Tavner, FJ
    Simpson, R
    Tashiro, S
    Favier, D
    Jenkins, NA
    Gilbert, DJ
    Copeland, NG
    Macmillan, EM
    Lutwyche, J
    Keough, RA
    Ishii, S
    Gonda, TJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (02) : 989 - 1002
  • [57] c-Myb acetylation at the carboxyl-terminal conserved domain by transcriptional co-activator p300
    Tomita, A
    Towatari, M
    Tsuzuki, S
    Hayakawa, F
    Kosugi, H
    Tamai, K
    Miyazaki, T
    Kinoshita, T
    Saito, H
    [J]. ONCOGENE, 2000, 19 (03) : 444 - 451
  • [58] TRANSCRIPTIONAL ACTIVATION BY THE V-MYB ONCOGENE AND ITS CELLULAR PROGENITOR, C-MYB
    WESTON, K
    BISHOP, JM
    [J]. CELL, 1989, 58 (01) : 85 - 93
  • [59] Myb-induced transformation
    Wolff, L
    [J]. CRITICAL REVIEWS IN ONCOGENESIS, 1996, 7 (3-4): : 245 - 260